A N Chremos - JoVE Visualize

Showing results (21-30 of 34) with videos related to

Pageof 4

Sort By:

Journal of Clinical Pharmacology|October 1, 1987

Disposition of famotidine in renal insufficiencyC E Halstenson, P A Abraham, J A Opsahl, et al.

Annals of Internal Medicine|June 1, 1993

Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemiaR H Bradford, M Downton, A N Chremos, et al.

Hypertension (Dallas, Tex. : 1979)|March 1, 1992

Lovastatin and coadministered antihypertensive/cardiovascular agentsJ L Pool, C L Shear, M Downton, et al.

Nephron|January 1, 1985

Sulindac and ibuprofen inhibit furosemide-stimulated renin release but not natriuresis in men on a normal sodium dietL J Riley, P H Vlasses, H H Rotmensch, et al.

Circulation|April 1, 1992

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteinsC L Shear, F A Franklin, S Stinnett, et al.

Pharmacotherapy|November 1, 1985

Steady-state disposition of diflunisal: once- versus twice-daily administrationP Mojaverian, M L Rocci, B N Swanson, et al.

The American Journal of Cardiology|September 18, 1990

Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemiaR H Bradford, C L Shear, A N Chremos, et al.

The American Journal of Medicine|July 31, 1991

Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatinC A Dujovne, A N Chremos, J L Pool, et al.

Archives of Internal Medicine|January 1, 1991

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemiaR H Bradford, C L Shear, A N Chremos, et al.

Biopharmaceutics & Drug Disposition|November 1, 1987

Single-dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studiesK C Yeh, A N Chremos, J H Lin, et al.

Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:

Pageof 4

Journal of Clinical Pharmacology|October 1, 1987

Disposition of famotidine in renal insufficiencyC E Halstenson, P A Abraham, J A Opsahl, et al.

Annals of Internal Medicine|June 1, 1993

Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemiaR H Bradford, M Downton, A N Chremos, et al.

Hypertension (Dallas, Tex. : 1979)|March 1, 1992

Lovastatin and coadministered antihypertensive/cardiovascular agentsJ L Pool, C L Shear, M Downton, et al.

Nephron|January 1, 1985

Sulindac and ibuprofen inhibit furosemide-stimulated renin release but not natriuresis in men on a normal sodium dietL J Riley, P H Vlasses, H H Rotmensch, et al.

Circulation|April 1, 1992

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteinsC L Shear, F A Franklin, S Stinnett, et al.

Pharmacotherapy|November 1, 1985

Steady-state disposition of diflunisal: once- versus twice-daily administrationP Mojaverian, M L Rocci, B N Swanson, et al.

The American Journal of Cardiology|September 18, 1990

Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemiaR H Bradford, C L Shear, A N Chremos, et al.

The American Journal of Medicine|July 31, 1991

Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatinC A Dujovne, A N Chremos, J L Pool, et al.

Archives of Internal Medicine|January 1, 1991

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemiaR H Bradford, C L Shear, A N Chremos, et al.

Biopharmaceutics & Drug Disposition|November 1, 1987

Single-dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studiesK C Yeh, A N Chremos, J H Lin, et al.

Pageof 4